Elsevier

Ophthalmology

Volume 122, Issue 8, August 2015, Pages 1645-1652
Ophthalmology

Original article
Corneal High-Order Aberrations and Backscatter in Fuchs' Endothelial Corneal Dystrophy

Presented in part at: the annual meetings of the Association for Research in Vision and Ophthalmology, Orlando, Florida, May 6, 2014, and Denver, Colorado, May 3, 2015.
https://doi.org/10.1016/j.ophtha.2015.05.005Get rights and content

Purpose

Suboptimal visual acuity after endothelial keratoplasty has been attributed to increased anterior corneal high-order aberrations (HOAs). In this study, we determined anterior and posterior corneal HOAs over a range of severity of Fuchs' endothelial corneal dystrophy (FECD).

Design

Cross-sectional study.

Participants

A total of 108 eyes (62 subjects) with a range of severity of FECD and 71 normal eyes (38 subjects).

Methods

All corneas were examined by using slit-lamp biomicroscopy to determine the severity of FECD versus normality. Fuchs' endothelial corneal dystrophy corneas were categorized as mild, moderate, or advanced according to the area and confluence of guttae and the presence of clinically visible edema. Normal corneas were devoid of any guttae. Wavefront errors from the anterior and posterior corneal surfaces were derived from Scheimpflug images and expressed as Zernike polynomials through the sixth order over a 6-mm diameter optical zone. Backscatter from the anterior 120 μm and posterior 60 μm of the cornea also was measured from Scheimpflug images and was standardized to a fixed scatter source. Variables were compared between FECD and control eyes by using generalized estimating equation models to adjust for age and correlation between fellow eyes.

Main Outcome Measures

High-order aberrations, expressed as root mean square of wavefront errors, and backscatter of the anterior and posterior cornea.

Results

Total anterior corneal HOAs were increased in moderate (0.61±0.27 μm, mean ± standard deviation; P = 0.01) and advanced (0.66±0.28 μm; P = 0.01) FECD compared with controls (0.47±0.16 μm). Total posterior corneal HOAs were increased in mild (0.22±0.09 μm; P = 0.017), moderate (0.22±0.08 μm; P < 0.001), and advanced (0.23±0.09 μm; P < 0.001) FECD compared with controls (0.16±0.03 μm). Anterior and posterior corneal backscatter were higher for all severities of FECD compared with controls (P ≤ 0.02, anterior; P ≤ 0.001, posterior).

Conclusions

Anterior and posterior corneal HOAs and backscatter are higher than normal even in early stages of FECD. The early onset of HOAs in FECD might contribute to the persistence of HOAs and incomplete visual rehabilitation after endothelial keratoplasty.

Section snippets

Subjects and Clinical Grading

All subjects were examined by cornea specialists using slit-lamp biomicroscopy. Severity of FECD was graded clinically on the basis of the area and confluence of guttae, and the presence of edema, as described previously.15, 16 Corneas with 1 to 12 or ≥12 nonconfluent central guttae (grades 1 and 2) were considered to have mild FECD; corneas with confluent guttae of 1- to 2-mm and 2- to 5-mm diameter (grades 3 and 4) were considered to have moderate FECD, and corneas with >5-mm diameter of

Subjects

A total of 108 corneas from 62 subjects with FECD and 71 normal corneas from 38 subjects were examined; the median age was 66 years (range, 40–89 years) (Table 1). Subjects with FECD were older than controls (mean difference, 7.9 years; P = 0.002). Subjects with mild (P = 0.01) and moderate (P = 0.03) FECD were more often pseudophakic than controls.

Corneal High-Order Aberrations

Data from 1 eye with FECD were excluded from analysis because of acquisition errors. Anterior corneal total HOAs were increased in moderate (P =

Discussion

Anterior corneal HOAs were increased in moderate and advanced FECD compared with controls, before clinically visible corneal edema, and posterior corneal HOAs and corneal backscatter were increased even in mild FECD. Increased posterior corneal HOAs and anterior and posterior corneal backscatter were associated with lower ECDe and thicker corneas in FECD. These data indicate that surface changes occur earlier than previously thought.

Increased anterior corneal HOAs in advanced FECD (with corneal

References (38)

  • A.P. Adamis et al.

    Fuchs' endothelial dystrophy of the cornea

    Surv Ophthalmol

    (1993)
  • L. Baydoun et al.

    Repeat Descemet membrane endothelial keratoplasty after complicated primary Descemet membrane endothelial keratoplasty

    Ophthalmology

    (2015)
  • K.M. Meek et al.

    Changes in the refractive index of the stroma and its extrafibrillar matrix when the cornea swells

    Biophys J

    (2003)
  • K. van Dijk et al.

    Near complete visual recovery and refractive stability in modern corneal transplantation: Descemet membrane endothelial keratoplasty (DMEK)

    Cont Lens Anterior Eye

    (2013)
  • E.R. Trousdale et al.

    Vision-related quality of life before and after keratoplasty for Fuchs' endothelial dystrophy

    Ophthalmology

    (2014)
  • S.V. Patel et al.

    Keratoplasty outcomes: are we making advances?

    Ophthalmology

    (2014)
  • S.E. Wilson et al.

    Fuchs' dystrophy

    Cornea

    (1988)
  • Eye Bank Association of America. 2013 Eye Banking Statistical Report. Available at:...
  • I. Dapena et al.

    Potential causes of incomplete visual rehabilitation at 6 months postoperative after Descemet membrane endothelial keratoplasty

    Am J Ophthalmol

    (2013)
  • Cited by (80)

    View all citing articles on Scopus

    Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

    Supported by Research to Prevent Blindness, New York, New York (unrestricted grant to the Department of Ophthalmology and support (to S.V.P.) as Olga Keith Wiess Special Scholar); Dr. Werner Jackstaedt-Stiftung, Wuppertal, Germany (Research Fellowship to K.W.); Mayo Clinic Center for Translational Science Activities (grant no. UL1 TR000135 from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health, Bethesda, MD); and Mayo Foundation, Rochester, Minnesota. The funding organizations had no role in the design or conduct of this research.

    Author Contributions:

    Conception and design: Wacker, McLaren, Amin, Baratz, Patel

    Data collection: Wacker, Amin, Patel

    Analysis and interpretation: Wacker, McLaren, Amin, Baratz, Patel

    Obtained funding: Not applicable

    Overall responsibility: Wacker, McLaren, Amin, Baratz, Patel

    View full text